Gleason Score Calculator
Determine your prostate cancer Gleason score based on biopsy results
Your Gleason Score Results
Primary Grade:
Secondary Grade:
Gleason Score:
Grade Group:
Risk Category:
Comprehensive Guide: How to Calculate Gleason Score for Prostate Cancer
The Gleason score is the most common grading system used to evaluate the prognosis of men with prostate cancer. Developed by Dr. Donald Gleason in the 1960s, this scoring system helps doctors determine how aggressive a prostate cancer is and guides treatment decisions.
Understanding the Gleason Grading System
When a pathologist examines prostate biopsy tissue under a microscope, they look at how the cancer cells are arranged in patterns. The Gleason grading system assigns a grade from 1 to 5 based on how abnormal the cancer cell patterns appear:
- Grade 1: The cancerous prostate tissue looks very similar to normal prostate tissue. The glands are small, well-formed, and closely packed.
- Grade 2: The tissue still has well-formed glands, but they are larger and have more stroma (connective tissue) between them.
- Grade 3: The glands vary in size and shape and are more infiltrative into the surrounding tissue.
- Grade 4: The tissue shows poorly formed, fused, or cribriform (sieve-like) glands.
- Grade 5: There is little to no gland formation. Sheets of cells or individual cells are seen infiltrating the surrounding tissue.
How the Gleason Score is Calculated
The Gleason score is calculated by:
- Identifying the most common (primary) pattern of cancer cell growth and assigning it a grade from 1 to 5
- Identifying the second most common (secondary) pattern and assigning it a grade from 1 to 5
- Adding these two grades together to get the Gleason score (ranging from 2 to 10)
For example, if the most common pattern is grade 3 and the second most common is grade 4, the Gleason score would be 3 + 4 = 7.
Gleason Score Groups and Risk Categories
In 2014, the International Society of Urological Pathology (ISUP) introduced Gleason Grade Groups to simplify the reporting of Gleason scores and make them more understandable for patients:
| Grade Group | Gleason Score | Risk Category | Description |
|---|---|---|---|
| 1 | ≤6 (3+3) | Very low risk | Cancer cells look similar to normal cells |
| 2 | 3+4=7 | Low risk | Mostly well-differentiated with some moderately differentiated cells |
| 3 | 4+3=7 | Intermediate risk | Mostly moderately differentiated with some well-differentiated cells |
| 4 | 8 (3+5, 4+4, 5+3) | High risk | Mostly moderately to poorly differentiated cells |
| 5 | 9-10 (4+5, 5+4, 5+5) | Very high risk | Mostly poorly differentiated cells |
Importance of Tertiary Patterns
In some cases, a third pattern (tertiary pattern) may be present in the biopsy. When this occurs:
- If the tertiary pattern is grade 5, it should be included in the Gleason score (e.g., 3+4=7 with tertiary 5 would be reported as 3+5=8)
- If the tertiary pattern is grade 4 and the primary is grade 3, it should be included (e.g., 3+3=6 with tertiary 4 would be reported as 3+4=7)
- Tertiary patterns are particularly important when they represent a higher grade than the primary or secondary patterns
Clinical Significance of Gleason Scores
The Gleason score is one of the most important factors in determining:
- The likelihood that the cancer will grow and spread
- The most appropriate treatment options
- The need for additional testing (like bone scans or MRI)
- The prognosis (expected outcome) of the disease
| Gleason Score | 5-Year Survival Rate | 10-Year Survival Rate | Common Treatment Options |
|---|---|---|---|
| ≤6 | 99% | 94% | Active surveillance, watchful waiting, surgery, radiation |
| 3+4=7 | 95% | 85% | Surgery, radiation (possibly with hormone therapy) |
| 4+3=7 | 90% | 70% | Surgery, radiation with hormone therapy |
| 8 | 80% | 50% | Surgery, radiation with hormone therapy, possibly chemotherapy |
| 9-10 | 60% | 30% | Aggressive treatment including surgery, radiation, hormone therapy, and chemotherapy |
Limitations of the Gleason Score
While the Gleason score is extremely valuable, it has some limitations:
- Sampling error: The biopsy may miss higher-grade cancer present in other areas of the prostate
- Subjectivity: There can be variability between pathologists in assigning grades
- Prostate heterogeneity: The prostate may contain multiple cancer foci with different grades
- Treatment effects: Prior treatments (like hormone therapy) can alter the appearance of cancer cells
Recent Advances in Prostate Cancer Grading
Several developments have improved prostate cancer grading in recent years:
- Grade Groups: The introduction of Grade Groups (1-5) has made it easier for patients to understand their prognosis
- MRI-targeted biopsies: MRI guidance helps target suspicious areas, reducing sampling errors
- Genomic testing: Tests like Decipher, Prolaris, and Oncotype DX can provide additional prognostic information
- Artificial Intelligence: AI systems are being developed to assist pathologists in grading
Frequently Asked Questions About Gleason Scores
Can my Gleason score change over time?
Yes, Gleason scores can change if you have additional biopsies or after prostate removal surgery. The score from the prostatectomy specimen is often considered more accurate than the biopsy score because the entire prostate is examined.
What’s the difference between a Gleason score of 3+4 and 4+3?
Both sum to 7, but they represent different risk levels. A 3+4 score means most of the cancer is well-differentiated (grade 3) with some moderately differentiated (grade 4) areas. A 4+3 score means most of the cancer is moderately differentiated (grade 4) with some well-differentiated (grade 3) areas. The 4+3 pattern is considered higher risk.
How does the Gleason score affect treatment options?
Lower Gleason scores (6 or 3+4=7) may be managed with active surveillance, especially in older men or those with other health conditions. Higher scores typically require more aggressive treatment like surgery or radiation, often combined with hormone therapy.
Is a Gleason score of 6 considered cancer?
Yes, but it’s considered very low-risk cancer. Some experts have proposed renaming Gleason 6 tumors as “IDLE” (indolent lesion of epithelial origin) to reflect their typically non-aggressive nature. However, they are still classified as cancer and require monitoring.
What should I do if I don’t understand my Gleason score?
Ask your urologist or oncologist to explain it in detail. You may also want to get a second opinion from another pathologist, as Gleason grading can be subjective. Understanding your score is crucial for making informed treatment decisions.